295 related articles for article (PubMed ID: 12767468)
41. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
42. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
[TBL] [Abstract][Full Text] [Related]
43. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
Bernstein DI; Ireland J; Bourne N
Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
[TBL] [Abstract][Full Text] [Related]
44. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
[TBL] [Abstract][Full Text] [Related]
45. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
46. Anti HSV-2 activity of Peganum harmala (L.) and isolation of the active compound.
Benzekri R; Bouslama L; Papetti A; Hammami M; Smaoui A; Limam F
Microb Pathog; 2018 Jan; 114():291-298. PubMed ID: 29223449
[TBL] [Abstract][Full Text] [Related]
47. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
48. Co-infection of acyclovir-resistant and acyclovir-sensitive herpes simplex type 2 virus strains in BS-C-1 cells.
Keywan K; Katz E
Intervirology; 1999; 42(4):247-51. PubMed ID: 10567843
[TBL] [Abstract][Full Text] [Related]
49. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
Ammendolia MG; Marchetti M; Superti F
Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
[TBL] [Abstract][Full Text] [Related]
50. Antiherpetic mechanism of a sulfated derivative of Agaricus brasiliensis fruiting bodies polysaccharide.
Cardozo FT; Camelini CM; Leal PC; Kratz JM; Nunes RJ; Mendonça MM; Simões CM
Intervirology; 2014; 57(6):375-83. PubMed ID: 25359160
[TBL] [Abstract][Full Text] [Related]
51. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.
Mitterreiter JG; Titulaer MJ; van Nierop GP; van Kampen JJ; Aron GI; Osterhaus AD; Verjans GM; Ouwendijk WJ
PLoS One; 2016; 11(5):e0155531. PubMed ID: 27171421
[TBL] [Abstract][Full Text] [Related]
53. Combined effects of interferon-alpha and acyclovir on herpes simplex virus type 1 DNA polymerase and alkaline DNase.
Taylor JL; Tom P; O'Brien WJ
Antiviral Res; 1998 May; 38(2):95-106. PubMed ID: 9707372
[TBL] [Abstract][Full Text] [Related]
54. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
[TBL] [Abstract][Full Text] [Related]
55. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
[TBL] [Abstract][Full Text] [Related]
56. Amentoflavone Inhibits HSV-1 and ACV-Resistant Strain Infection by Suppressing Viral Early Infection.
Li F; Song X; Su G; Wang Y; Wang Z; Jia J; Qing S; Huang L; Wang Y; Zheng K; Wang Y
Viruses; 2019 May; 11(5):. PubMed ID: 31121928
[TBL] [Abstract][Full Text] [Related]
57. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.
Aboudy Y; Mendelson E; Shalit I; Bessalle R; Fridkin M
Int J Pept Protein Res; 1994 Jun; 43(6):573-82. PubMed ID: 7928088
[TBL] [Abstract][Full Text] [Related]
58. 2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.
Strand M; Islam K; Edlund K; Oberg CT; Allard A; Bergström T; Mei YF; Elofsson M; Wadell G
Antimicrob Agents Chemother; 2012 Nov; 56(11):5735-43. PubMed ID: 22908173
[TBL] [Abstract][Full Text] [Related]
59. Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation.
Chayrov RL; Stylos EK; Chatziathanasiadou MV; Chuchkov KN; Tencheva AI; Kostagianni AD; Milkova TS; Angelova AL; Galabov AS; Shishkov SA; Todorov DG; Tzakos AG; Stankova IG
Amino Acids; 2018 Aug; 50(8):1131-1143. PubMed ID: 29779181
[TBL] [Abstract][Full Text] [Related]
60. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
